{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:56Z","timestamp":1786119416999,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1097\/iae.0b013e3181ca1457","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T02:28:00Z","timestamp":1269484080000},"page":"S24-S31","source":"Crossref","is-referenced-by-count":59,"title":["TREATMENT OF TYPE 1 RETINOPATHY OF PREMATURITY WITH INTRAVITREAL BEVACIZUMAB (AVASTIN)"],"prefix":"10.1097","volume":"30","author":[{"given":"PAOLA","family":"DORTA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDR\u00c9S","family":"KYCHENTHAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archopht.1988.01060130517027","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results.","volume":"106","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"R2-6-20210130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archopht.123.3.311","article-title":"15-Year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity.","volume":"123","author":"Palmer","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R3-6-20210130","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R4-6-20210130","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0161-6420(03)00831-5","article-title":"Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study.","volume":"110","author":"Ells","year":"2003","journal-title":"Ophthalmology"},{"key":"R5-6-20210130","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/IAE.0b013e31815e987f","article-title":"The photographic screening for retinopathy of prematurity study (photo-ROP). Primary outcomes.","volume":"28","year":"2008","journal-title":"Retina"},{"key":"R6-6-20210130","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1001\/archopht.1992.01080240054029","article-title":"Diode laser photocoagulation for retinopathy of prematurity. Preliminary results.","volume":"110","author":"McNamara","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"R7-6-20210130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0002-9394(14)71402-3","article-title":"Diode-laser photocoagulation for zone 1 threshold retinopathy of prematurity.","volume":"116","author":"Capone","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"R8-6-20210130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0161-6420(93)31664-7","article-title":"Diode laser photocoagulation for threshold retinopathy of prematurity. A randomized study.","volume":"100","author":"Hunter","year":"1993","journal-title":"Ophthalmology"},{"key":"R9-6-20210130","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0161-6420(99)00042-1","article-title":"A comparison of dense versus less dense diode laser photocoagulation patterns for threshold retinopathy of prematurity.","volume":"107","author":"Banach","year":"2000","journal-title":"Ophthalmology"},{"key":"R10-6-20210130","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.ophtha.2004.06.021","article-title":"Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity.","volume":"111","author":"Prenner","year":"2004","journal-title":"Ophthalmology"},{"key":"R11-6-20210130","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0161-6420(01)00809-0","article-title":"Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments.","volume":"108","author":"Capone","year":"2001","journal-title":"Ophthalmology"},{"key":"R12-6-20210130","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.ophtha.2004.05.030","article-title":"Lens-sparing vitrectomy for stage 4 retinopathy of prematurity.","volume":"111","author":"Hubbard","year":"2004","journal-title":"Ophthalmology"},{"key":"R13-6-20210130","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/IAE.0b013e318159ec49","article-title":"25-gauge lens-sparing vitrectomy for stage 4A retinopathy of prematurity.","volume":"28","author":"Kychenthal","year":"2008","journal-title":"Retina"},{"key":"R14-6-20210130","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1067\/mpa.2000.107904","article-title":"Zone I retinopathy of prematurity.","volume":"4","author":"Katz","year":"2004","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"R15-6-20210130","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/01.iae.0000244285.79004.e6","article-title":"Zone I retinopathy of prematurity: clinical characteristics and treatment outcomes.","volume":"26","author":"Kychenthal","year":"2006","journal-title":"Retina"},{"key":"R16-6-20210130","first-page":"493","article-title":"Long-term visual outcomes in extremely low-birth-weight children (an American Ophthalmological Society thesis).","volume":"104","author":"Spencer","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R17-6-20210130","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/bjo.84.12.1383","article-title":"Diode laser treatment of posterior retinopathy of prematurity.","volume":"84","author":"Axer-Siegel","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R18-6-20210130","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1395-3907.2003.00171.x","article-title":"Outcome of zone I retinopathy of prematurity.","volume":"81","author":"O'Keefe","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"R19-6-20210130","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","article-title":"Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia.","volume":"15","author":"Stone","year":"1995","journal-title":"J Neurosci"},{"key":"R20-6-20210130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","article-title":"Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.","volume":"28","author":"Mintz-Hittner","year":"2008","journal-title":"Retina"},{"key":"R21-6-20210130","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00417-007-0661-y","article-title":"Combination of laser photocoagulation and intravitreal bevacizumab (Avastin\u00ae) for aggressive zone I retinopathy of prematurity.","volume":"245","author":"Chung","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R22-6-20210130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3928\/15428877-20070501-09","article-title":"Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.","volume":"38","author":"Travassos","year":"2007","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R23-6-20210130","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/IAE.0b013e318159ec6b","article-title":"Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity.","volume":"28","author":"Quiroz-Mercado","year":"2008","journal-title":"Retina"},{"key":"R24-6-20210130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control.","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum Dev"},{"key":"R25-6-20210130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/01.iae.0000225766.75009.3a","article-title":"Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"26","author":"Rich","year":"2006","journal-title":"Retina"},{"key":"R26-6-20210130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/IAE.0b013e318186c64e","article-title":"The effect of unilateral intravitreal bevacizumab (Avastin), in the treatment of diffuse bilateral diabetic macular edema: a pilot study.","volume":"29","author":"Velez-Montoya","year":"2009","journal-title":"Retina"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0b013e3181ca1457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:11:46Z","timestamp":1786039906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201004001-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181ca1457","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}